Source:http://linkedlifedata.com/resource/pubmed/id/11511422
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2001-8-20
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
1388-9842
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
3
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
395-7
|
| pubmed:dateRevised |
2011-6-8
|
| pubmed:meshHeading |
pubmed-meshheading:11511422-Atrial Natriuretic Factor,
pubmed-meshheading:11511422-Biological Markers,
pubmed-meshheading:11511422-Heart Failure,
pubmed-meshheading:11511422-Humans,
pubmed-meshheading:11511422-Prognosis,
pubmed-meshheading:11511422-Sensitivity and Specificity,
pubmed-meshheading:11511422-Severity of Illness Index
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
The value of natriuretic peptides for the management of heart failure: current state of play.
|
| pubmed:publicationType |
Editorial,
Comment
|